
Create your profile now and gain access to exclusive deals and high-potential startups.




i2o Therapeutics: Innovating oral formulations for traditionally injectable therapies.

Synereca Pharmaceuticals innovates orally-active drugs to enhance existing antibiotics' effectiveness.

Forward Therapeutics: Innovating chronic inflammatory treatment through advanced oral immune therapies.

Synnovation Therapeutics: Precision oncology firm specializing in small molecule therapies for cancer.

LumiThera, Inc.: Innovating non-invasive ocular devices for treating acute and chronic eye disorders.

i-Lumen Scientific: Innovating noninvasive therapies for dry age-related macular degeneration.

Vivid Vision: Pioneering unique vision tests and treatments with cutting-edge technology.

Oculomotor Technologies: Providing vision therapy tools for optometry practices.

US-based Lyndra Therapeutics develops therapies for Alzheimer's, HIV, opioid use disorder, and schizophrenia.

Lyric, a clinical-stage company, innovates gastrointestinal therapeutics for unmet hospital needs.

Cara Therapeutics, a Connecticut-based medical firm, develops novel drugs for pain and inflammation treatment.

Cyrano Therapeutics: Innovating intranasal solutions to restore taste and smell functions.

Perosphere Technologies: Innovating coagulation diagnostics and drug delivery systems for actionable healthcare.

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

PleoPharma: A high-ethics pharmaceutical firm dedicated to addressing significant medical needs.

Pharmaceutical R&D firm, Solaris Pharma, specializes in generic and specialty products.

Arizona-based Predictive Biomarker Sciences develops innovative cancer treatment technologies for pharmaceutical research.

Predictive Health Diagnostics: Transforming data into intelligent, science-driven diagnostic tests.

Castle Biosciences, Inc.: A U.S. biotech firm offering diagnostic and prognostic cancer testing solutions.

Previse: Pioneering early cancer detection through affordable, accurate biomarker technology, starting with esophageal cancer.

Micro Medical Solutions develops microvascular intervention therapies for peripheral artery disease.

Atlanta-based Micron Biomedical, Inc. specializes in commercial physical and biological R&D since 2012.

Micro Interventional Devices pioneers disruptive tech for minimally invasive heart repair procedures.

ELum Technologies: Innovating endovascular disease solutions through disruptive medical devices.


